A bacteriophage journey at the European Medicines Agency
- PMID: 26656541
- PMCID: PMC5812529
- DOI: 10.1093/femsle/fnv225
A bacteriophage journey at the European Medicines Agency
Abstract
The seriously and globally increasing bacterial multi-drug resistance calls out on concerted counteractive measures: international health authorities give consideration to the therapeutical use of bacteriophage therapy.
References
-
- Carlet J. Overcoming global antimicrobial resistance. 2015 AMR control. WAAAR. ( http://www.globalhealthdynamics.co.uk/wp-content/uploads/2015/06/01_Carl...) (3 December 2015, date last accessed)
-
- Kutter EM, Kuhl SJ, Abedon ST. Re-establishing a place for phage therapy in western medicine. Future Microbiol. 2015;10:685–8. - PubMed
-
- Międzybrodzki R, Borysowski J, Weber-Dąbrowska B, et al. Clinical aspects of phage therapy. Adv Virus Res. 2012;83:73–121. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical